44 studies found for:    " January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (44 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
2 Active, not recruiting Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
3 Active, not recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF
4 Recruiting Living Well Project for Persons With AIDS
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
5 Recruiting Switching Undetectables to Selzentry
Conditions: Human Immunodeficiency Virus;   AIDS
Intervention: Drug: Maraviroc
6 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
7 Recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
8 Not yet recruiting Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
9 Active, not recruiting An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
10 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
11 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
12 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Drug: brentuximab vedotin;   Other: pharmacological study;   Other: laboratory biomarker analysis
13 Completed A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
14 Recruiting Mater-Bronx Rapid HIV Testing Project.
Condition: Human Immunodeficiency Virus
Interventions: Other: No participant choice of counselor;   Other: Participant choice of counselor
15 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
16 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
17 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
18 Recruiting Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Suubi+Adherence;   Behavioral: Bolstered Standard of Care
19 Active, not recruiting Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
Conditions: HIV;   Hepatitis B;   Hepatitis C;   Carcinoma, Hepatocellular;   AIDS
Interventions: Other: ELISA;   Other: Rapid Test
20 Enrolling by invitation TDF Long Term Study
Condition: HIV-infected Thai Children
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years